约 2,170 个结果
在新选项卡中打开链接
FDA Approves First Subcutaneous Infliximab Product - Center for …
FDA Approves Avzivi, the Fifth Biosimilar to Avastin
FDA Approves Sandoz's Pegfilgrastim Biosimilar, Ziextenzo
Canada Approves High-Concentration Humira Biosimilar
FDA Approves Fifth Pegfilgrastim Biosimilar, Fylnetra
FDA Approves Epysqli as Second Soliris Biosimilar - Center for …
Ahzantive Receives FDA Approval as New Eylea Biosimilar
Biogen, Xbrane Enter Commercialization Agreement for Cimzia …
Center for Biosimilars®
FDA Approves Samsung Bioepis’ Pyzchiva, a Biosimilar to Stelara